Recombinant OPRD1 anticorps
Aperçu rapide pour Recombinant OPRD1 anticorps (ABIN7127652)
Antigène
Voir toutes OPRD1 AnticorpsType d'anticorp
Reactivité
Hôte
Clonalité
Conjugué
Application
Clone
-
-
Fonction
- OPRD1 Recombinant Monoclonal Antibody
-
Réactivité croisée
- Souris
-
Purification
- Affinity-chromatography
-
Immunogène
- A synthesized peptide derived from human OPRD1
-
Isotype
- IgG
-
-
-
-
Indications d'application
- WB:1:500-1:5000
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- phosphate buffered saline, pH 7.4, 150 mM NaCl, 0.02 % sodium azide and 50 % glycerol.
-
Agent conservateur
- Sodium azide
-
Précaution d'utilisation
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Stock
- -20 °C,-80 °C
-
Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
-
- OPRD1 (Opioid Receptor, delta 1 (OPRD1))
-
Autre désignation
- OPRD1
-
Sujet
-
Background: G-protein coupled receptor that functions as receptor for endogenous enkephalins and for a subset of other opioids. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling leads to the inhibition of adenylate cyclase activity. Inhibits neurotransmitter release by reducing calcium ion currents and increasing potassium ion conductance. Plays a role in the perception of pain and in opiate-mediated analgesia. Plays a role in developing analgesic tolerance to morphine.
Aliases: Delta-type opioid receptor (D-OR-1) (DOR-1), OPRD1, OPRD
-
UniProt
- P41143
-
Pathways
- Protein targeting to Nucleus
Antigène
-